BRKB

481.25

+0.09%↑

BRKA.US

721,729.2

+0.11%↑

JPM

292.71

+0.41%↑

V

303.86

-0.92%↓

MA

499.64

-1.08%↓

BRKB

481.25

+0.09%↑

BRKA.US

721,729.2

+0.11%↑

JPM

292.71

+0.41%↑

V

303.86

-0.92%↓

MA

499.64

-1.08%↓

BRKB

481.25

+0.09%↑

BRKA.US

721,729.2

+0.11%↑

JPM

292.71

+0.41%↑

V

303.86

-0.92%↓

MA

499.64

-1.08%↓

BRKB

481.25

+0.09%↑

BRKA.US

721,729.2

+0.11%↑

JPM

292.71

+0.41%↑

V

303.86

-0.92%↓

MA

499.64

-1.08%↓

BRKB

481.25

+0.09%↑

BRKA.US

721,729.2

+0.11%↑

JPM

292.71

+0.41%↑

V

303.86

-0.92%↓

MA

499.64

-1.08%↓

Search

Hanover Insurance Group Inc-The

Отворен

СекторФинансови

172.87 0.76

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

169.8

Максимум

172.98

Ключови измерители

By Trading Economics

Приходи

20M

199M

Продажби

14M

1.7B

P/E

Средно за сектора

9.589

54.048

EPS

5.79

Дивидентна доходност

2.11

Марж на печалбата

11.873

Служители

4,900

EBITDA

35M

272M

Препоръки

By TipRanks

Препоръки

Купи

12-месечна прогноза

+20.23% upside

Дивиденти

By Dow Jones

Дивидентна доходност

Средно за сектора

2.11%

4.84%

Следващи печалби

29.04.2026 г.

Следваща дата на дивидент

27.03.2026 г.

Следваща дата на екс-дивидент

12.06.2026 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

-135M

6.1B

Предишно отваряне

172.11

Предишно затваряне

172.87

Настроения в новините

By Acuity

50%

50%

160 / 441 Класиране в Finance

Техническа оценка

By Trading Central

Увереност

Weak Bearish Evidence

Hanover Insurance Group Inc-The Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

23.03.2026 г., 23:47 ч. UTC

Придобивния, сливания и поглъщания

Gilead Sciences to Buy Ouro Medicines, Collaborate With Galapagos on Purchased Assets -- Update

23.03.2026 г., 22:55 ч. UTC

Придобивния, сливания и поглъщания

Gilead Sciences to Buy Ouro Medicines for Up to $2.18 Billion

23.03.2026 г., 21:51 ч. UTC

Придобивния, сливания и поглъщания

Italy's Postal Service Makes $12.50 Billion Bid for Telecom Italia -- 3rd Update

23.03.2026 г., 23:59 ч. UTC

Пазарно говорене

Global Equities Roundup: Market Talk

23.03.2026 г., 23:59 ч. UTC

Пазарно говорене

Woodside, Santos Earnings Power Up on Surging LNG Prices -- Market Talk

23.03.2026 г., 23:50 ч. UTC

Пазарно говорене

Nikkei May Rise on Hopes for U.S. Talks With Iran -- Market Talk

23.03.2026 г., 23:37 ч. UTC

Пазарно говорене

Gold Rises, Boosted by Fall in Dollar, U.S. Treasury Yields -- Market Talk

23.03.2026 г., 22:42 ч. UTC

Пазарно говорене
Значими събития в новините

Global Equities Roundup: Market Talk

23.03.2026 г., 22:42 ч. UTC

Пазарно говорене
Значими събития в новините

Bell Potter Names Miners Less Exposed to Fuel Price, Supply Risks -- Market Talk

23.03.2026 г., 22:40 ч. UTC

Придобивния, сливания и поглъщания

Gilead Sciences to Buy Ouro Medicines for Up to $2.18B

23.03.2026 г., 22:23 ч. UTC

Пазарно говорене

Apollo Debt Solutions Shrugs Off Private-Credit Fears -- Market Talk

23.03.2026 г., 22:22 ч. UTC

Придобивния, сливания и поглъщания

Gilead Sciences: OM336 Is for Treatment of Autoantibodies Driven Immune-Mediated Disease

23.03.2026 г., 22:21 ч. UTC

Придобивния, сливания и поглъщания

Gilead Sciences: Company Would Pay Galapagos Royalties of 20%-23% of Net OM336 Sales

23.03.2026 г., 22:21 ч. UTC

Придобивния, сливания и поглъщания

Gilead Sciences: Company Would Retain Sole Worldwide Commercialization Rights of OM336 Outside of Greater China

23.03.2026 г., 22:20 ч. UTC

Придобивния, сливания и поглъщания

Gilead Sciences: Company, Galapagos Would Collaborate on Development of OM336 >GILD

23.03.2026 г., 22:20 ч. UTC

Придобивния, сливания и поглъщания

Gilead Sciences: Galapagos Would Absorb Substantially All of Ouro's Operating Assets, Retain Its Employees >GILD

23.03.2026 г., 22:19 ч. UTC

Придобивния, сливания и поглъщания

Gilead Sciences: Galapagos Would Pay 50% of Upfront Consideration and 50% of Any Contingent Milestone Payments Payable to Ouro Shareholders

23.03.2026 г., 22:19 ч. UTC

Придобивния, сливания и поглъщания

Gilead Sciences: Currently in Advanced Discussions With Galapagos With Respect to Potential Research-and-Development Collaboration on Acquired Ouro Assets

23.03.2026 г., 22:18 ч. UTC

Придобивния, сливания и поглъщания

Gilead Sciences to Buy Ouro Medicines for About $1.68B Upfront, Up to $500M in Contingent Milestone Payments >GILD

23.03.2026 г., 22:15 ч. UTC

Придобивния, сливания и поглъщания

Gilead Sciences To Acquire Ouro Medicines To Advance First In Class T Cell Engager Program For Autoimmune Diseases >GILD

23.03.2026 г., 22:08 ч. UTC

Пазарно говорене

Ebos Needs to Reset Its Gearing Targets -- Market Talk

23.03.2026 г., 21:42 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

23.03.2026 г., 21:42 ч. UTC

Пазарно говорене

RBNZ's Breman Strikes Reassuring Tone On Rates -- Market Talk

23.03.2026 г., 21:32 ч. UTC

Печалби

WuXi XDC Cayman: Results Aided by Strong Growth in Contract Research, Development and Manufacturing Organisation Business>2268.HK

23.03.2026 г., 21:32 ч. UTC

Печалби

WuXi XDC Cayman 2025 Net CNY1.56B Vs. Net CNY917.16M >2268.HK

23.03.2026 г., 21:32 ч. UTC

Печалби

WuXi XDC Cayman 2025 Rev CNY5.94B Vs. CNY4.05B >2268.HK

23.03.2026 г., 21:10 ч. UTC

Значими събития в новините

Oil Is Back Under $100. Trump Says Iran Has Agreed to No Nuclear Weapons. -- Barrons.com

23.03.2026 г., 20:50 ч. UTC

Пазарно говорене

Tech, Media & Telecom Roundup: Market Talk

23.03.2026 г., 20:50 ч. UTC

Пазарно говорене

Health Care Roundup: Market Talk

23.03.2026 г., 20:50 ч. UTC

Пазарно говорене
Печалби
Значими събития в новините

Basic Materials Roundup: Market Talk

Сравнение с други в отрасъла

Ценова промяна

Hanover Insurance Group Inc-The Прогноза

Ценова цел

By TipRanks

20.23% нагоре

12-месечна прогноза

Среден 203 USD  20.23%

Висок 210 USD

Нисък 194 USD

Според 4 анализатори от Wall Street, предложили 12-месечна ценова цел за Hanover Insurance Group Inc-The през последните три месеца.

Консенсусна оценка

By TipRanks

Купи

4 ratings

2

Купи

2

Задържане

0

Продай

Техническа оценка

By Trading Central

165.99 / 166.43Подкрепа & съпротива

Краткосрочен план

Weak Bearish Evidence

Средносрочен план

Bullish Evidence

Дългосрочен план

Bullish Evidence

Настроение

By Acuity

160 / 441 Класиране в Финансови

Настроения в новините

Neutral

Волатилност

Под средното

Обем новини (RCV)

Среден

Финанси

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно Hanover Insurance Group Inc-The

The Hanover Insurance Group, Inc., through its subsidiaries, provides various property and casualty insurance products and services in the United States. The company operates through four segments: Core Commercial, Specialty, Personal Lines, and Other. The Commercial Lines segment offers commercial multiple peril, commercial automobile, workers' compensation, and other commercial lines coverage. The Specialty segment provides professional and executive Lines, marine, and surety and other, as well as specialty property and casualty, such as program business, specialty industrial business, excess and surplus business, and specialty general liability coverage. The Personal Lines segment offers personal automobile and homeowner's coverages, as well as other personal coverages, such as personal umbrella, inland marine, fire, personal watercraft, personal cyber, and other miscellaneous coverages. The Other segment markets investment advisory services to institutions, insurance companies, pension funds, and other organizations. The Hanover Insurance Group, Inc. markets its products and services through independent agents and brokers. The company was formerly known as Allmerica Financial Corp. and changed its name to The Hanover Insurance Group, Inc. in December 2005. The Hanover Insurance Group, Inc. was founded in 1852 and is headquartered in Worcester, Massachusetts.
help-icon Live chat